// App-Quantinova.ai

TCT-38 : Ticagrelor With and Without Aspirin in Patients With Previous Coronary Artery Bypass Graft Undergoing Percutaneous Coronary Intervention: The TWILIGHT-CABG Subanalysis

Researchers

Presenter

  • Frans Beerkens

Principal Investigators

  • George Dangas

  • Samantha Sartori

  • Zhongjie Zhang

  • Johny Nicolas

  • Anton Camaj

  • Bimmer Claessen

  • Carlo Andrea Pivato

  • David Power

  • Victor Razuk

  • Davis Jones

  • Dominick Angiolillo

  • Shamir Mehta

  • C. Michael Gibson

  • Gennaro Sardella

  • Samin Sharma

  • Richard Shlofmitz

  • Timothy Collier

  • Stuart Pocock

  • Roxana Mehran

Medical Centers

  • Icahn School of Medicine at Mount Sinai, New York, New York, USA

  • Department of Biomedical Sciences, Humanitas University, Milan, Italy

  • Hamilton Health Sciences, Hamilton, Ontario, Canada

  • Amsterdam University Medical Centers, Amsterdam, the Netherlands

  • London School of Hygiene and Tropical Medicine, London, United Kingdom

  • Policlinico Umberto I University, Rome, Italy

  • University of Florida, Jacksonville, Florida, USA

  • Mount Sinai Medical Center, Scarsdale, New York, USA

  • Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA

  • St Francis Hospital, Roslyn, New York, USA

Locations

  • United States

  • Italy

  • Canada

  • Netherlands

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Central Nervous System (CNS)

Disease

  • Myocardial infarction

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Ticagrelor

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved